Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: VIII Madrid Breast Cancer Conference: Latest Advances in Breast Cancer

Poster presentation

Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

E Amir, R Broom, O Freedman, WS Ooi, S Done, D Gianfelice, D Barth, H Kahn and M Clemons

Breast Cancer Research 2009, 11(Suppl 1):P27 doi:10.1186/bcr2310

No comments have yet been made on this article.

Post a comment